Annual Accounts Payable
$1.60 M
-$962.00 K-37.49%
December 31, 2023
Summary
- As of February 7, 2025, VYGR annual accounts payable is $1.60 million, with the most recent change of -$962.00 thousand (-37.49%) on December 31, 2023.
- During the last 3 years, VYGR annual accounts payable has risen by +$970.00 thousand (+153.00%).
- VYGR annual accounts payable is now -60.59% below its all-time high of $4.07 million, reached on December 31, 2019.
Performance
VYGR Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$3.16 M
+$555.00 K+21.31%
September 30, 2024
Summary
- As of February 7, 2025, VYGR quarterly accounts payable is $3.16 million, with the most recent change of +$555.00 thousand (+21.31%) on September 30, 2024.
- Over the past year, VYGR quarterly accounts payable has increased by +$1.56 million (+97.01%).
- VYGR quarterly accounts payable is now -58.31% below its all-time high of $7.58 million, reached on March 31, 2024.
Performance
VYGR Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
VYGR Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -37.5% | +97.0% |
| 3 y3 years | +153.0% | +23.1% |
| 5 y5 years | +54.5% | +23.1% |
VYGR Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -37.5% | +179.4% | -58.3% | +450.5% |
| 5 y | 5-year | -60.6% | +179.4% | -58.3% | +450.5% |
| alltime | all time | -60.6% | +191.6% | -58.3% | +929.3% |
Voyager Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $3.16 M(+21.3%) |
| Jun 2024 | - | $2.60 M(-65.6%) |
| Mar 2024 | - | $7.58 M(+372.5%) |
| Dec 2023 | $1.60 M(-37.5%) | $1.60 M(-50.9%) |
| Sep 2023 | - | $3.27 M(+97.1%) |
| Jun 2023 | - | $1.66 M(-55.1%) |
| Mar 2023 | - | $3.70 M(+44.1%) |
| Dec 2022 | $2.57 M(+347.0%) | $2.57 M(+91.9%) |
| Sep 2022 | - | $1.34 M(+9.8%) |
| Jun 2022 | - | $1.22 M(+1.5%) |
| Mar 2022 | - | $1.20 M(+109.1%) |
| Dec 2021 | $574.00 K(-9.5%) | $574.00 K(-3.0%) |
| Sep 2021 | - | $592.00 K(-25.1%) |
| Jun 2021 | - | $790.00 K(-75.1%) |
| Mar 2021 | - | $3.18 M(+401.1%) |
| Dec 2020 | $634.00 K(-84.4%) | $634.00 K(-81.3%) |
| Sep 2020 | - | $3.39 M(+65.6%) |
| Jun 2020 | - | $2.04 M(-57.5%) |
| Mar 2020 | - | $4.82 M(+18.3%) |
| Dec 2019 | $4.07 M | $4.07 M(+1.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $4.03 M(+80.5%) |
| Jun 2019 | - | $2.23 M(-1.4%) |
| Mar 2019 | - | $2.26 M(+117.8%) |
| Dec 2018 | $1.04 M(+1.8%) | $1.04 M(-27.0%) |
| Sep 2018 | - | $1.42 M(-8.7%) |
| Jun 2018 | - | $1.56 M(+13.6%) |
| Mar 2018 | - | $1.37 M(+34.5%) |
| Dec 2017 | $1.02 M(+85.5%) | $1.02 M(+12.0%) |
| Sep 2017 | - | $911.00 K(+196.7%) |
| Jun 2017 | - | $307.00 K(-44.9%) |
| Mar 2017 | - | $557.00 K(+1.3%) |
| Dec 2016 | $550.00 K(-10.1%) | $550.00 K(-30.1%) |
| Sep 2016 | - | $787.00 K(+73.3%) |
| Jun 2016 | - | $454.00 K(-73.2%) |
| Mar 2016 | - | $1.70 M(+177.3%) |
| Dec 2015 | $612.00 K(-60.6%) | $612.00 K(+13.1%) |
| Sep 2015 | - | $541.00 K(-62.9%) |
| Jun 2015 | - | $1.46 M(-6.1%) |
| Dec 2014 | $1.55 M(+63.6%) | $1.55 M |
| Dec 2013 | $950.00 K | - |
FAQ
- What is Voyager Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Voyager Therapeutics?
- What is Voyager Therapeutics annual accounts payable year-on-year change?
- What is Voyager Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Voyager Therapeutics?
- What is Voyager Therapeutics quarterly accounts payable year-on-year change?
What is Voyager Therapeutics annual accounts payable?
The current annual accounts payable of VYGR is $1.60 M
What is the all time high annual accounts payable for Voyager Therapeutics?
Voyager Therapeutics all-time high annual accounts payable is $4.07 M
What is Voyager Therapeutics annual accounts payable year-on-year change?
Over the past year, VYGR annual accounts payable has changed by -$962.00 K (-37.49%)
What is Voyager Therapeutics quarterly accounts payable?
The current quarterly accounts payable of VYGR is $3.16 M
What is the all time high quarterly accounts payable for Voyager Therapeutics?
Voyager Therapeutics all-time high quarterly accounts payable is $7.58 M
What is Voyager Therapeutics quarterly accounts payable year-on-year change?
Over the past year, VYGR quarterly accounts payable has changed by +$1.56 M (+97.01%)